Medifast's decision to increase marketing spending amid dema...
Medifast's decision to increase marketing spending amid demand headwinds has alarmed investors, leading to a 10.1% drop in the company's stock price, despite exceeding revenue expectations.
Medifast (NYSE:MED) Exceeds Q4 Expectations But Stock Drops 10.1%
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment